Cotización F-star Therapeutics, Inc.
Acciones
FSTX
US30315R1077
Biotecnología e investigación médica
Directores | Puesto | Edad | Desde |
---|---|---|---|
Neil Brewis
CEO | Chief Executive Officer | 57 | 20/11/20 |
Lindsey Trickett
IRC | Investor Relations Contact | - | - |
Trish Hurley
LAW | General Counsel | - | - |
Administradores | Puesto | Edad | Desde |
---|---|---|---|
Neil Brewis
CEO | Chief Executive Officer | 57 | 20/11/20 |
Varia. 1 de ene. | Capi. | |
---|---|---|
+2,73 % | 108 mil M | |
+9,59 % | 103 mil M | |
+6,58 % | 23,48 mil M | |
-12,59 % | 21,93 mil M | |
-3,29 % | 19,68 mil M | |
-35,36 % | 18,37 mil M | |
-13,29 % | 16,33 mil M | |
+4,68 % | 13,72 mil M | |
+34,25 % | 12,15 mil M |